Two days after the FDA revealed that it had halted enrollment in trials of respiratory syncytial virus (RSV) vaccines that ...
Following news of RSV lower respiratory tract infections in infants immunized with Moderna’s investigational RNA vaccines, ...
After several severe RSV cases were reported in a pediatric trial of Moderna's vaccine, the FDA has partially paused testing ...
MedPage Today on MSN2d
FDA Advisors Say More Data Needed for RSV Vaccines in Young KidsFDA advisors said that more data are needed to fully understand if there are broader safety concerns related to use of ...
The FDA has since put a hold on enrolling children under 2 years old and those ages 2 through 5 who have never been exposed ...
A briefing document from the Food and Drug Administration (FDA) says that enrollment for all clinical studies of vaccines for ...
The FDA has placed a hold on all clinical studies of vaccines for respiratory syncytial virus in infants due to safety concerns following a trial involving two mRNA-based vaccine candidates from ...
Cases of severe RSV in two Moderna vaccine candidates' trials raise questions about future
Ahead of an advisory committee meeting later this week, the FDA revealed that all studies for RSV vaccines in young children ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.DyCR3BqR.js ...
Not providing some services in languages other than English is a violation of civil rights. It can also create public health ...
MinterEllison has advised Moderna in relation to its new mRNA manufacturing facility – a facility described by the firm as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback